Terumo Medical Pranex
基本情報
- 所在地
- Tokyo, Japan
- 社長
- 資本金
- 従業員数(単独)
- 従業員数(連結)
- 開始日
- 終了日
サイト
事業内容
関連会社
| 会社名 | Group | 親会社 | 子会社 | 得意先 | 仕入先 | 業務提携 | 銀行等 | 株主等 |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| Terumo Hospital Care Solutions | ||||||||
| Terumo Life Care Solutions | ||||||||
| Terumo Neuro | ||||||||
| Terumo Organ Technologies | ||||||||
| Terumo Pharmaceutical Solutions | ||||||||
| テルモヒューマンクリエイト株式会社 | ||||||||
| Pharma Alliance | ||||||||
|
|
||||||||
| テルモビジネスサポート株式会社 | ||||||||
|
|
||||||||
| ファーマシューティカル | ||||||||
|
|
||||||||
| 血液・細胞テクノロジーカンパニー |
関連図
沿革
Founded by doctors including Dr. Kitasato Shibasaburo, aiming for domestically produced high-quality thermometers, and established Red Line Thermometry Co., Ltd.
Decided on the name and launched the 'Jintan Thermometer'.
Changed the company name to Jintan Thermometer Co., Ltd.
Launched the world's first disposable syringe to enhance medical safety, entering the disposable medical device field.
Launched Japan's first disposable needle.
Launched Japan's first blood bag, supporting Japan's blood industry.
Terumo Medical Company established
Terumo Europe Company established
Launched Japan's first soft bag infusion solution based on accumulated technology in blood bag development
Changed company name from "Jintan Terumo Corporation" to the current "Terumo Corporation"
Launched hollow fiber artificial kidney (dialyzer) and entered the artificial organ field
Launched Japan's first high-calorie infusion basic solution in soft bags
Launched the world's first porous hollow fiber artificial lung
Increased capital to 2.6 billion yen through a public offering of 12 million shares (public offering price 1,220 yen) and listed on the Second Section of the Tokyo Stock Exchange
Launched hospital predictive electronic thermometer
Ceased production of flat mercury thermometers to be environmentally friendly (packaging process ended on March 20, 1985)
Reclassified company's stock to the First Section of the Tokyo Stock Exchange
Launched vascular angiography catheter system and entered the vascular catheter diagnosis and treatment field
Launched peritoneal dialysis system and entered the home medical care field
Established Shonan Center research and development facility
Launched blood glucose measurement system and entered the diabetes field
Established "Terumo Medical Products (Hangzhou) Co., Ltd." in Hangzhou, Zhejiang Province, China
Established a joint venture "Changchun Terumo Medical Devices Co., Ltd." in Changchun, Jilin Province, China, for manufacturing, development, and sales of blood bags
Established a joint venture "Terumo Penpole" with Penpole in India as the second overseas blood bag production base
Acquired the artificial heart-lung business from 3M in the United States and established Terumo Cardiovascular Systems
Launched prefilled syringes (drug-filled syringes)
Start of operations at Terumo Philippines
Launched a closed infusion system
Signed agreements to acquire the home oxygen business from Sumitomo Bakelite Co., Ltd., and to acquire 93% of the shares of Medical Research Co., Ltd., which manufactures and sells concentrated oxygen devices, etc.
Established Terumo Medical Care Co., Ltd., acquiring Sumitomo Bakelite's business. Operations began on November 1
Business transfer of the dialysis business to Asahi Medical Co., Ltd.
Construction of Terumo Medical Plenax
A manufacturer and seller of artificial blood vessels, British company Vascutek, joins the Terumo Group
Launched the world's first high-calorie infusion agent containing multivitamins
Launched the world's thinnest insulin and other injection needles
A manufacturer and seller of neurovascular devices, MicroVention Inc. in the U.S., joins the Terumo Group and launches coils for intracranial embolization
Acquired the artificial heart valve business from German company Kola
Established Olympus Terumo Biomaterials Co.
Launched implantable left ventricular assist system in Europe
Launched drug-eluting coronary stents in Europe
Acquired shares of Clinical Supply, a manufacturer and seller in the field of catheter-based cancer chemotherapy (Interventional Oncology, IO), and established Terumo Clinical Supply Co., Ltd.
Established Terumo Americas Holdings
The U.S. company Calidian BCT (now Terumo BCT), specializing in blood and cell technology, joins the Terumo Group
Acquired Harvest Technologies, a U.S. company with advanced technology in cell therapy and related fields
Launch of implantable left ventricular assist device in Japan
Expanding business in the Chinese market and applying for the establishment of a holding company, Terumo (China) Investment Co., Ltd.
Established Terumo Yamaguchi Co., Ltd.
Terumo Americas Holdings acquires all shares of Onset Medical Corporation and gains large-bore sheath technology used in cardiovascular catheter treatments
Establishment of a holding company, Terumo Asia Holdings, in Singapore
Opened
Participated in the United Nations Global Compact
Launched infusion bags with anti-tampering mechanisms
Launched infusion delivery system compatible with hospital IT
Launched Frozen Elephant Trunk in Europe
Established a joint venture with China's Weigao Group for peritoneal dialysis business
Built and held a completion ceremony for a blood-related products manufacturing plant in Ho Chi Minh City, operated by Terumo BCT, Inc. (Colorado, USA)
Established and began operations of the local sales subsidiary Terumo Russia
Established Terumo India Private Ltd. to expand business in India
Launched series of measurement devices with communication functions
Established Terumo Medical Innovation, Inc.
Launched human (autologous) skeletal muscle cell sheet (2016)
Added the world's first pouch-type embolization device to the cerebral aneurysm treatment lineup
Launched Japan's first patch-type insulin pump
Announced new business brand
Acquired Chinese company Essentec Technology Beijing Co., Ltd., a manufacturer and seller of cardiac catheter products
Revamped corporate philosophy system, established core values shared by employees alongside the unchanging corporate philosophy, and revised the Terumo Group Code of Conduct
Launch of filling and finishing systems to strengthen the cell therapy field
Strengthening the cell therapy field
Terumo BCT establishes as a new 'Blood and Cell Technology Company' to strengthen the cell therapy field
Celebrating its 100th anniversary
Launch of raw plasma collection system in the United States
Announcement of new company brand 'Terumo Medical Care Solutions'
Establishment of 'Terumo South Africa'
ニュース
ニュースはありません。